Provided by Tiger Trade Technology Pte. Ltd.

Vericel

42.30
-0.3800-0.89%
Volume:812.27K
Turnover:34.53M
Market Cap:2.17B
PE:90.18
High:43.34
Open:42.68
Low:41.95
Close:42.68
52wk High:49.32
52wk Low:28.95
Shares:51.21M
Float Shares:50.46M
Volume Ratio:1.52
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4691
EPS(LYR):0.3200
ROE:7.16%
ROA:2.43%
PB:5.85
PE(LYR):132.19

Loading ...

Vericel Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 08

Analysts Offer Insights on Healthcare Companies: Vericel (VCEL) and BridgeBio Pharma (BBIO)

TIPRANKS
·
May 08

Vericel reports Q1 EPS (12c), consensus (16c)

TIPRANKS
·
May 08

Vericel Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Vericel Q1 EPS $(0.12) Beats $(0.15) Estimate, Sales $68.425M Beat $63.638M Estimate

Benzinga Earnings
·
May 07

Stock Track | Vericel Soars 5.38% in Pre-market on Strong Q1 Results and Raised Full-Year Guidance

Stock Track
·
May 07

Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook

Reuters
·
May 07

GUIDANCE: (VCEL) Vericel Expects 2026 Total Revenue Range $326M to $336M, vs. FactSet Est of $323.4M

MT Newswires Live
·
May 07

Earnings Flash (VCEL) Vericel Posts Q1 Net Loss $0.12 a Share, vs. FactSet Est of $0.15 Loss

MT Newswires Live
·
May 07

BRIEF-Vericel Q1 EPS USD -0.12

Reuters
·
May 07

Vericel Q1 Gross Profit USD 49.266 Million

THOMSON REUTERS
·
May 07

Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

GlobeNewswire
·
May 07

Vericel Shareholders Reaffirm Board, Pay Plan, Auditor

TIPRANKS
·
May 02

Vericel shareholders approved director slate at annual meeting

Reuters
·
May 02

Earning Preview: Vericel revenue is expected to increase by 18.19%, and institutional views are mostly bullish

Earnings Agent
·
Apr 30

Canaccord Genuity Remains a Buy on Vericel (VCEL)

TIPRANKS
·
Apr 24

Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

GlobeNewswire
·
Apr 23

Vericel Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 15

Truist Cuts Price Target on Vericel to $42 From $48, Keeps Buy Rating

MT Newswires Live
·
Apr 15

Vericel CMO Jonathan Hopper disposes of common shares worth $121,520

Reuters
·
Apr 07